Category: Workers Comp

499 posts found

Support for Marijuana Continues to Grow Across the Nation

A flurry of recent developments continues to bring the medical marijuana debate front and center, including further legalization, a Senate bill, a drug approval, and more.

Clinical Insights

JAMA Study Questions the Effectiveness of Negative Pressure Wound Therapy

In a randomized clinical trial of 460 patients, researchers found the treatment to have similar impact on self-rated disability as standard wound dressing.

Healthe Developments

Healthesystems at WCIEC Orlando 2018

Visit Healthesystems in booth #914 to see how we explore the conference’s “Cosmic” theme, and for a chance to win a $250 gift card.

Medmonitor

Drug Approvals Impacting Workers’ Comp

The FDA recently approved drugs to treat opioid dependence, migraines, and rheumatoid arthritis.

This Month's Must Read

The Burden of Opioid-Related Mortality in the United States

Among many findings, JAMA reports that 20% of deaths among those aged 25-34 were opioid-related.

Legislation & Policy

More States Pass Opioid Prescription Limits

Within the last month, laws have passed in Tennessee, Colorado, South Carolina, Oklahoma, and Hawaii.

Clinical Insights

IQVIA Reports on Global Oncology Trends

Global spending on cancer therapies now exceeds $133 billion.

Healthe Developments

Healthe Leaders Comment on Clinical Use of Marijuana & MDMA

Our Chief Medical Officer and VP of Clinical Services comment on the clinical use of ecstasy and marijuana.

Medmonitor

FDA Encourages Drug Developers to Focus on Buprenorphine Depot Products

A newly released draft guidance encourages the development of more sustained-release buprenorphine products.

This Month's Must Read

WCRI Releases CompScope Benchmarks

In-depth reports for 16 different states examine medical payments, costs, duration of disability, and more.

Legislation & Policy

Illinois Bill May Allow Patients to Trade Opioids for Marijuana

Senate Bill 336 passed with a 44-6 vote and is now headed to the House.

Clinical Insights

The Craze Over Kratom

Kratom continues to grow in popularity as a drug for pain and opioid withdrawal, despite concerns from the FDA, CDC and DEA.

Healthe Developments

Four Current and Near-Future Drug Trends Impacting Rx Management

In a special partner post with WorkCompWire, Healthesystems discusses developments in pain management, specialty drugs, and more.

Medmonitor

Opioid Withdrawal Drug Closer to Approval

If approved, Lucemyra (lofexidine) would be the first non-opioid drug approved to treat the symptoms of opioid withdrawal.

This Month's Must Read

Dr. Silvia Sacalis Discusses Value-Based Care with WorkCompWire

Healthesystems’ VP of Clinical Services discusses how workers’ comp is embracing a value-driven approach.

Prev 1 2 3 4 5 … 30 31 32 33 34 Next